Junwei Shi
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 0.5%
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- CRISPR and Genetic Engineering
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- Protein Degradation and Inhibitors 22
- Epigenetics and DNA Methylation 16
- RNA modifications and cancer 15
- CRISPR and Genetic Engineering 15
- Ubiquitin and proteasome pathways 7
- Hematology 22
- Acute Myeloid Leukemia Research 12
- Multiple Myeloma Research and Treatments 8
- Co-authors
- Christopher R. Vakoc (24 shared papers)Eric Wang (8 shared papers)Joseph P. Milazzo (5 shared papers)Johannes Zuber (5 shared papers)Scott W. Lowe (5 shared papers)Amy Rappaport (4 shared papers)Meredith J. Taylor (3 shared papers)Justin B. Kinney (4 shared papers)
- Journals
- Blood (18 papers)Molecular Cell (5 papers)Nature Biotechnology (4 papers)Cancer Research (3 papers)Nature Genetics (3 papers)
- Partner nations
- United StatesChinaAustria
In The Last Decade
Junwei Shi
95 papers receiving 7.5k citations
Junwei Shi's Hit Papers
Peers
Comparison fields: 5 of 114
- Hematology 1.4k
- Molecular Biology 6.2k
- Cancer Research 723
- Oncology 1.3k
- Aging 72
Countries citing papers authored by Junwei Shi
This map shows the geographic impact of Junwei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Shi more than expected).
Fields of papers citing papers by Junwei Shi
This network shows the impact of papers produced by Junwei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Shi. The network helps show where Junwei Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Junwei Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1479 |
| 2 | Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control Hit paper breakdown → | 2017 | 839 |
| 3 | The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition Hit paper breakdown → | 2014 | 679 |
| 4 | Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains Hit paper breakdown → | 2015 | 523 |
| 5 | 2010 | 451 | |
| 6 | 2018 | 270 | |
| 7 | 2018 | 262 | |
| 8 | 2013 | 261 | |
| 9 | 2011 | 213 | |
| 10 | 2018 | 157 | |
| 11 | 2016 | 138 | |
| 12 | 2012 | 127 | |
| 13 | 2016 | 122 | |
| 14 | 2015 | 116 | |
| 15 | 2018 | 111 | |
| 16 | 2021 | 110 | |
| 17 | 2013 | 100 | |
| 18 | 2012 | 97 | |
| 19 | 2018 | 95 | |
| 20 | 2020 | 82 |
About Junwei Shi
Junwei Shi is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Immunology, having authored 104 papers that have together received 7.6k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (22 papers), Hemoglobinopathies and Related Disorders (19 papers), Epigenetics and DNA Methylation (16 papers), RNA modifications and cancer (15 papers), CRISPR and Genetic Engineering (15 papers), Acute Myeloid Leukemia Research (12 papers), Multiple Myeloma Research and Treatments (8 papers) and Ubiquitin and proteasome pathways (7 papers). The work is most often cited by research in Hematology (1.4k citations), Molecular Biology (6.2k citations), Cancer Research (723 citations), Oncology (1.3k citations) and Aging (72 citations). Junwei Shi has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Christopher R. Vakoc, Eric Wang, Joseph P. Milazzo, Johannes Zuber, Scott W. Lowe, Amy Rappaport, Meredith J. Taylor, Justin B. Kinney, Jun Qi and Scott C. Kogan. Their work appears in journals such as Blood, Molecular Cell, Nature Biotechnology, Cancer Research and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.